Podrobno

Vpliv joge na kakovost življenja treh oseb z multiplo sklerozo : diplomsko delo
ID Zaletel, Tina (Avtor), ID Filipčič, Tjaša (Mentor) Več o mentorju... Povezava se odpre v novem oknu, ID Terčon, Jerneja (Komentor)

URLURL - Predstavitvena datoteka, za dostop obiščite http://pefprints.pef.uni-lj.si/id/eprint/2340 Povezava se odpre v novem oknu

Jezik:Slovenski jezik
Ključne besede:multipla skleroza, joga, kakovost življenja
Vrsta gradiva:Diplomsko delo
Tipologija:2.11 - Diplomsko delo
Organizacija:PEF - Pedagoška fakulteta
Kraj izida:Ljubljana
Založnik:[T. Zaletel]
Leto izida:2014
Št. strani:VIII, 75 str.
PID:20.500.12556/RUL-29746 Povezava se odpre v novem oknu
UDK:616.832-004:615.851.8(043.2)
COBISS.SI-ID:10155849 Povezava se odpre v novem oknu
Datum objave v RUL:02.10.2014
Število ogledov:4760
Število prenosov:426
Metapodatki:XML DC-XML DC-RDF
:
ZALETEL, Tina, 2014, Vpliv joge na kakovost življenja treh oseb z multiplo sklerozo : diplomsko delo [na spletu]. Diplomsko delo. Ljubljana : T. Zaletel. [Dostopano 29 marec 2025]. Pridobljeno s: http://pefprints.pef.uni-lj.si/id/eprint/2340
Kopiraj citat
Objavi na:Bookmark and Share

Podobna dela

Podobna dela v RUL:
  1. ǂThe ǂimportance of cancer stem cells and epithelial-mesenchymal transition in the progression of non-small cell lung cancer
  2. Gene expression levels of the prolyl hydroxylase domain proteins PHD1 and PHD2 but not PHD3 are decreased in primary tumours and correlate with poor prognosis of patients with surgically resected non-small-cell lung cancer
  3. Study of phosphatidylethanolamine N-methyltransferase gene expression in non-small cell lung cancer tissue
  4. Usefulness of immunohistochemically determined epidermal growth factor receptor mutations in lung cancer
  5. Diabetes mellitus and physical activity
Podobna dela v drugih slovenskih zbirkah:
  1. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer
  2. Outsourcing predictive biomarker testing in non-small cell carcinoma
  3. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  4. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. NSCLC molecular testing in Central and Eastern European countries

Nazaj